How Litfulo Offers New Hope for Alopecia Areata
Alopecia areata, an autoimmune disorder causing hair loss, has traditionally been challenging to treat. Conventional therapies often lack effectiveness and come with side effects. The emergence of Litfulo, a targeted JAK inhibitor, offers renewed hope. By directly addressing the condition’s inflammatory processes, Litfulo provides a promising alternative, shifting the treatment landscape for alopecia areata. The […]
3 minute read